SARS-CoV2, COVID-19, HFNC, COT, Oxygen therapy.
Showing 1 - 25 of >10,000
Non-invasive Respiratory Support on Outcome and Its Risks in
Active, not recruiting
- COVID-19
- Hypoxemic Respiratory Failure
- High flow nasal oxygen (HFNO, more than 15 L/min)
-
Rotterdam, Zuid-Holland, NetherlandsErasmus MC
Sep 4, 2023
Corona Virus Infection, ARDS Due to Disease Caused by Severe Acute Respiratory Syndrome Coronavirus 2, Oxygen Deficiency Trial
Not yet recruiting
- Corona Virus Infection
- +2 more
- Oxygen theraphy with high flow nasal cannule
- Oxygen theraphy with mask with reservoir
-
Szczecin, Zachodniopomorskie, PolandOxygen Therapy Sector of Temporary Hospital
Jan 18, 2022
Cognitive Decline, COVID-19, SARS CoV 2 Infection Trial in Hangzhou (hyperbaric oxygen therapy, conventional oxygen therapy)
Not yet recruiting
- Cognitive Decline
- +2 more
- hyperbaric oxygen therapy
- conventional oxygen therapy
-
Hangzhou, Zhejiang, ChinaFirst Affiliated Hospital of Zhejiang Chinese Medical University
Feb 6, 2023
COVID-19, Post-COVID-19 Syndrome, Influenza Trial in Kunming (Autonomous Treatment System for Covid-19, Post-Acute Sequelae of
Enrolling by invitation
- COVID-19
- +2 more
- Autonomous Treatment System for Covid-19, Post-Acute Sequelae of SARS-CoV-2 Infection and Influenza Based on Machine Learning
-
Kunming, Yunnan, ChinaSheng'Ai Traditional Medicine Hospital
Sep 22, 2023
Immunogenicity, Safety Trial (Phase II:SWIM816;SARS-Cov-2;, Phase II:SW-BIC-213;SARS-Cov-2;, PhaseIII:SWIM816;SARS-Cov-2;)
Not yet recruiting
- Immunogenicity
- Safety
- Phase II:SWIM816;SARS-Cov-2;
- +3 more
- (no location specified)
Jun 18, 2023
COVID-19 Trial (NVX-CoV2601 co-formulated Omicron XBB.1.5 SARS-CoV-2 rS vaccine, Prototype/XBB.1.5 Bivalent Vaccine (5 µg))
Not yet recruiting
- COVID-19
- NVX-CoV2601 co-formulated Omicron XBB.1.5 SARS-CoV-2 rS vaccine
- Prototype/XBB.1.5 Bivalent Vaccine (5 µg)
- (no location specified)
Aug 4, 2023
COVID-19 Vaccine, COVID-19 Trial in Bangkok (50 µg Baiya SARS-CoV-2 Vax 2, Placebo)
Not yet recruiting
- COVID-19 Vaccine
- COVID-19
- 50 μg Baiya SARS-CoV-2 Vax 2
- Placebo
-
Bangkok, ThailandQueen Saovabha Memorial Institute
May 23, 2023
Covid-19 Trial in Marseille, Toulon (Hyperbaric oxygen treatment (HBOT) i.e. inhalation of pressurized oxygen delivered by a
Recruiting
- Covid-19
- Hyperbaric oxygen treatment (HBOT) i.e. inhalation of pressurized oxygen delivered by a hyperbaric chamber (drug/device)
-
Marseille, France
- +2 more
Feb 14, 2022
Security Efficacy COVID-19 Vaccination
Completed
- Autoimmune State
- SARS-CoV-2 Infection
- Blood sampling
-
Milan, ItalyIstituto Auxologico Italiano IRCCS
Feb 23, 2023
Covid19 Trial in Cypress (VXA-CoV2-1)
Completed
- Covid19
- VXA-CoV2-1
-
Cypress, CaliforniaWCCT
Jan 17, 2023
a Randomized Double-blind Study, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), PHYTOTHERAPIE Trial in Sahloul
Completed
- a Randomized Double-blind Study
- +2 more
-
Sahloul, Sousse, TunisiaRiadh Boukef
Jan 2, 2023
SARS-CoV-2 Infection, COVID-19, Coronavirus Trial in Marseille, Nîmes (eBAM Cov Testing)
Not yet recruiting
- SARS-CoV-2 Infection
- +2 more
- eBAM Cov Testing
-
Marseille, France
- +1 more
Oct 23, 2023
COVID-19 Trial in Vigo (Convalescent plasma)
Completed
- COVID-19
- Convalescent plasma
-
Vigo, SpainHospital Álvaro Cunqueiro
Oct 5, 2022
Zinc Deficiency, Sars-CoV-2 Infection Trial in Barcelona (Zinc Acetate)
Completed
- Zinc Deficiency
- Sars-CoV-2 Infection
- Zinc Acetate
-
Barcelona, SpainHospital del Mar
Mar 18, 2023
COVID-19 Transmission and Morbidity in Malawi
Recruiting
- SARS CoV 2 Infection
- SARS CoV 2 Vaccination
-
Boston, Massachusetts
- +1 more
Aug 6, 2023
Awake Prone Positioning in COVID-19 ICU Patients
Not yet recruiting
- SARS-CoV 2 Pneumonia
- quality of life questionnaire
-
Tours, Franceuniversity hospital Tours
Oct 10, 2023
Vitamin A and E Deficiency With Severity of SARS-COV-2 Disease:
Completed
- COVID-19
-
Cairo, None Selected, Egyptbalsam Sherif Fahmy
Jul 12, 2023
A Study of the Effectiveness of Moderna COVID-19 Vaccine
Recruiting
- SARS-CoV-2
- COVID-19
- mRNA-1273
-
Pasadena, CaliforniaKaiser Permanente Southern California
Jul 5, 2023
SARS-CoV-2/COVID-19 Study of Next Generation Non-Invasive
Not yet recruiting
- COVID-19
- +5 more
- imPulse™ Una infrasound-to-ultrasound e-stethoscope
- (no location specified)
Mar 9, 2023
Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor, Symptomatic COVID-19 Infection Laboratory-Confirmed Trial in
Recruiting
- Hematopoietic and Lymphoid Cell Neoplasm
- +2 more
- SARS-CoV-2 Antigen-specific Cytotoxic T-lymphocytes
-
Houston, TexasM D Anderson Cancer Center
Jul 13, 2022
COVID-19 Infection and SARS-CoV-2 Antibodies in MS Patients
Completed
- Multiple Sclerosis
- Covid19
-
New York, New YorkNYU Langone Health
Nov 2, 2022
Long-Term Sequelae of SARS-COV-2 Infection: Diabetes Mellitus
Not yet recruiting
- COVID-19
- Diabete Mellitus
- Measure of physiologic parameters
-
San Antonio, TexasTexas Diabetes Institute - University Health System
May 17, 2023
Sars-Covid-19 Vaccines in Haematological Patients: Prospective
Completed
- Hematologic Diseases
- IgG antibodies to Sars-Cov-2
- QuantiFERON SARS-CoV-2 test
-
Monza, Lombardia, ItalySan Gerardo Hospital
Jan 23, 2023
Sustained Immunity to COVID-19 as Measured by SARS-CoV-2
Recruiting
- Covid19
- Serologic immunoassays to SARS-CoV-2 antibodies
-
Detroit, MichiganHenry Ford Health System
Dec 13, 2022